Skip to main content
. 2024 Feb 23;78(5):1222–1231. doi: 10.1093/cid/ciae098

Figure 4.

Figure 4.

Antibiotic treatment (and retreatment) pathways for laboratory-confirmed tularemia cases (n = 327). Rectangles represents retreatment. aIncluding 2 cases combined with 5 d of tobramycin (not requiring further retreatment). bOther treatments included: rifampicin/isoniazid/pyrazinamide/ethambutol for tuberculosis regimen (n = 1), and erythromycin (n = 1). cIn combination with vancomycin (n = 1), ciprofloxacin (n = 2).